Tag: #Global Trends

Objecting plaintiffs have formally filed a notice of appeal on Wednesday challenging the judicial decision issued by Judge Autrey. The... Read more

Four years after sustaining a regulatory rejection in 2022, British pharmaceutical giant GSK and its partner Spero Therapeutics have scored... Read more

Global biopharmaceutical giant Merck & Co. has finalized a strategic multi-year licensing and research collaboration agreement with Protillion Biosciences. The... Read more

The U.S. Food and Drug Administration (FDA) has officially commenced its formal regulatory review of Gilead Sciences’ once-weekly oral prescription... Read more

A cyber extortion group has claimed to have exfiltrated over a terabyte of proprietary data from Danish pharmaceutical behemoth Novo... Read more

U.S. Food and Drug Administration staff reviewers announced on Tuesday that immunogenicity data tracking an active immune response to Moderna’s... Read more

Moderna Chief Executive Officer Stephane Bancel told the German business daily Handelsblatt on Wednesday (June 17, 2026) that the United... Read more

Colorado-based biotechnology firm Edgewise Therapeutics has announced that its investigational cardiovascular compound, EDG-7500, successfully met the primary objectives of its... Read more

Eli Lilly and Company has officially announced definitive data from its global Phase 3 BRUIN CLL-322 clinical trial. The landmark... Read more